Suppr超能文献

与转移性肾细胞癌中免疫检查点抑制剂相关的结节病样反应(SLR)

Sarcoid-Like Reaction (SLR) Associated With Immune Checkpoint Inhibitors in Metastatic Renal Cell Carcinoma.

作者信息

Fukushima Kanta, Mizukoshi Sota, Ino Tomohiro, Ishida Takuya, Ito Yumika, Okimura Akira, Nakatsugawa Munehide, Hashimoto Takeshi

机构信息

Department of Urology Tokyo Medical University Hachioji Medical Center Tokyo Japan.

Department of Urology Tokyo Medical University Tokyo Japan.

出版信息

IJU Case Rep. 2025 Apr 14;8(3):285-288. doi: 10.1002/iju5.70027. eCollection 2025 May.

Abstract

INTRODUCTION

Immune checkpoint inhibitors (ICIs) are useful in the treatment of metastatic renal cell carcinoma. ICIs have been associated with a variety of immune-related adverse events (irAEs), one of which is a sarcoid-like reaction (SLR). SLR is often difficult to distinguish from cancer progression.

CASE PRESENTATION

The patient is a 71-year-old woman. She underwent laparoscopic nephrectomy after 4 courses of ipilimumab + nivolumab therapy for clear cell renal cell carcinoma with femoral bone metastasis. In the pathological examination, in addition to tumor-infiltrating lymphocytes, numerous non-caseating epithelioid cell granulomas were found in the tumor. The occurrence of non-caseating epithelioid cell granuloma in a patient who did not meet the diagnostic criteria for systemic sarcoidosis was considered SLR due to ICI.

CONCLUSIONS

We report the first case of a patient who underwent surgery for metastatic renal cell carcinoma after treatment with ICI and who was pathologically diagnosed with SLR in the kidney.

摘要

引言

免疫检查点抑制剂(ICIs)在转移性肾细胞癌的治疗中很有用。ICIs与多种免疫相关不良事件(irAEs)有关,其中之一是类肉瘤样反应(SLR)。SLR常常难以与癌症进展相区分。

病例介绍

该患者为一名71岁女性。她因伴股骨转移的透明细胞肾细胞癌接受了4个疗程的伊匹单抗+纳武单抗治疗后,接受了腹腔镜肾切除术。在病理检查中,除了肿瘤浸润淋巴细胞外,在肿瘤中还发现了大量非干酪样上皮样细胞肉芽肿。在一名不符合系统性结节病诊断标准的患者中出现非干酪样上皮样细胞肉芽肿,考虑为ICI所致的SLR。

结论

我们报告了首例在接受ICI治疗后因转移性肾细胞癌接受手术且在肾脏病理诊断为SLR的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/538a/12055221/4b42ae190d25/IJU5-8-285-g004.jpg

相似文献

1
Sarcoid-Like Reaction (SLR) Associated With Immune Checkpoint Inhibitors in Metastatic Renal Cell Carcinoma.
IJU Case Rep. 2025 Apr 14;8(3):285-288. doi: 10.1002/iju5.70027. eCollection 2025 May.
4
5
A case of sarcoidosis-like reaction associated with immune checkpoint inhibitors in metastatic renal cell carcinoma.
IJU Case Rep. 2021 Sep 24;5(1):15-18. doi: 10.1002/iju5.12372. eCollection 2022 Jan.
8
Immune Checkpoint Inhibitor-Associated Sarcoidosis Reaction in the Kidney: Case Report.
Kidney Med. 2023 Mar 13;5(5):100626. doi: 10.1016/j.xkme.2023.100626. eCollection 2023 May.

本文引用的文献

1
Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Ann Oncol. 2022 Dec;33(12):1217-1238. doi: 10.1016/j.annonc.2022.10.001. Epub 2022 Oct 18.
2
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update.
J Clin Oncol. 2021 Dec 20;39(36):4073-4126. doi: 10.1200/JCO.21.01440. Epub 2021 Nov 1.
3
Drug-induced sarcoidosis-like reaction in adjuvant immunotherapy: Increased rate and mimicker of metastasis.
Eur J Cancer. 2020 May;131:18-26. doi: 10.1016/j.ejca.2020.02.024. Epub 2020 Apr 2.
4
Sarcoid-like reaction associated with renal cell carcinoma - A case report.
Respir Med Case Rep. 2019 Apr 15;27:100847. doi: 10.1016/j.rmcr.2019.100847. eCollection 2019.
5
Immune checkpoint inhibitors and the development of granulomatous reactions.
J Am Acad Dermatol. 2019 Nov;81(5):1165-1175. doi: 10.1016/j.jaad.2018.07.051. Epub 2018 Aug 6.
6
Sarcoidosis-Like Reactions Induced by Checkpoint Inhibitors.
J Thorac Oncol. 2018 Aug;13(8):1076-1082. doi: 10.1016/j.jtho.2018.04.031. Epub 2018 May 12.
10
Radiographic Profiling of Immune-Related Adverse Events in Advanced Melanoma Patients Treated with Ipilimumab.
Cancer Immunol Res. 2015 Oct;3(10):1185-92. doi: 10.1158/2326-6066.CIR-15-0102. Epub 2015 Jun 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验